BioRestorative Therapies, Inc.
BRTX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001505497
No open-market purchases or sales by BioRestorative Therapies, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.00M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in BioRestorative Therapies, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- 0 vs. Q4 2024
- Shares held
- 281.9K
- −1.70K (−0.6%) vs. Q4 2024
- Total value
- $501.8K
- +$96.2K (+23.7%) vs. Q4 2024
- New holders
- 1
- 8 more added
- Sold out
- 1
- 1 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.00M |
| Q1 2026 | 14 | $184.2K |
| Q4 2025 | 16 | $383.4K |
| Q3 2025 | 17 | $550.3K |
| Q2 2025 | 18 | $413.9K |
| Q1 2025 | 17 | $501.8K |
| Q4 2024 | 17 | $405.6K |
| Q3 2024 | 17 | $471.9K |
| Q2 2024 | 15 | $520.0K |
| Q1 2024 | 15 | $531.0K |
| Q4 2023 | 15 | $540.9K |
| Q3 2023 | 15 | $648.7K |
| Q2 2023 | 14 | $1.42M |
| Q1 2023 | 17 | $1.02M |
| Q4 2022 | 18 | $900.4K |
| Q3 2022 | 19 | $1.16M |
| Q2 2022 | 16 | $975.1K |
| Q1 2022 | 17 | $1.80M |
| Q4 2021 | 13 | $1.72M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 2 | $12.0K |
| Q1 2021 | 1 | $30.0K |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding BioRestorative Therapies, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 59,997 | $106.8K | 0.00% | +5,275+9.6% | Added |
| StoneX Group Inc. | 51,192 | $91.1K | 0.00% | +1,049+2.1% | Added |
| Wealth Alliance | 40,000 | $71.2K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 38,000 | $67.6K | 0.00% | +10,500+38.2% | Added |
| Vanguard Group Inc | 29,730 | $52.9K | 0.00% | +9,258+45.2% | Added |
| State Street Corp | 20,459 | $36.4K | 0.00% | 00.0% | Unchanged |
| US Financial Advisors, LLC | 17,142 | $30.5K | 0.01% | 00.0% | Unchanged |
| Newman Dignan & Sheerar, Inc. | 11,522 | $20.5K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 8,346 | $14.9K | 0.00% | −7,951−48.8% | Reduced |
| Tower Research Capital LLC (TRC) | 3,197 | $5.69K | 0.00% | +1,620+102.7% | Added |
| Advisor Group Holdings, Inc. | 2,193 | $3.90K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 74 | $132 | 0.00% | +14+23.3% | Added |
| Bank of America Corp | 43 | $77 | 0.00% | +1+2.4% | Added |
| Rossby Financial, LCC | 12 | $21 | 0.00% | +12 | New |
| TD Waterhouse Canada Inc. | 3 | $5 | 0.00% | +1+50.0% | Added |
| Cornerstone Planning Group LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −21,481−100.0% | Sold out |